Reason for request
Radiation
Arrêt du remboursement suite à un arrêt de commercialisation.
Avis favorable à l’arrêt du remboursement de la spécialité IMBRUVICA (ibrutinib) 140 mg, gélule dans les indications de l’AMM.
eNq1mFFv2jAQx9/5FFHeSQKUlk2BamPthtRqjBZt2gtykqOYBTs920D36ecQutHJUVtTSzxAHP53ufv751Pi8+0q99aAgnLW91tB5HvAUp5Rdtf3p7eXzZ5/PmjES7ImB7edBVHQavtemhMh+n65GiRAmAh+XF99Av1/QH/Q8GKeLCGVT+5TkubBFyIW16Qo7/HiNaeZtwK54FnfL5TcXfViIVFnMdhw/CUKkkIc7q8cri5nJ4fX47AUe4GqEoBXhN0ZRYFZaaYKEZgcEgl3HB+M0vN01u6dnUZRzyoEFRMQXGEKYyIXY+RrmkFmjkRyAVZB5pvsBnCdgyyDGMXDZboSVuJkSbYTuB+Zk/6gV4dyK5tRs3V22jlpd6Ooa1ssPCiV2Tz6IcJi1ul02voTAgvpKkG1pilpUv1FUkYTyz6NOUqSO+oQFcOnXnMUB+H+WSdkVBQ5eQiWorAtFUGilwE1Edw9SPkEt6gZleua/afPVJ6Hr8x6uieIo4xLQA25YrIGJJcT20IMOZOwre+oHfvkdu9FCuLtZH9zZub+WCU5TW3xpgGkQMjpZFRPN1dg+EgETNEdGb5TlvGNeHviHHbYUfbFDppG0QKz1qz9rnfa6natN9RPbaeak+dCIS8g1Cyi4hjEjNicHwsX7VCz1KM/nVhzNxLxlORQMxQ1LZmjPfk4wzlzvbsdVS0YRT9f3Npa5ZsCfLjZ/TRK06z/t8l2QHZBeW3M2sRfb/Nqt79gXD7pWRZBoRkmCykL8T4MN5tNsCCiKYguVjBHp+A/OHfdDe5ODvdq2Kng6Sj1pDoVX9ct28333PF/7Ei7//9+dDbGkKjgiF5UnHZG09HF2wP63zzrLO3xE6C4C7ObPYmknLmag1RiHoKOOhJ0X9klakB8nc9pzfuUWl/GYfUuZ9CIw/I9zqDxBz+J+xQ=
STyQkmwZQ4PFArFW
Listen
